These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10630428)

  • 21. Serologic testing for inflammatory bowel disease.
    Hoffenberg EJ; Fidanza S; Sauaia A
    J Pediatr; 1999 Apr; 134(4):447-52. PubMed ID: 10190919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic value of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibody in Iranian patients with inflammatory bowel disease.
    Bahari A; Aarabi M; Aarabi M; Hedayati M; Jarollahi A; Firouzi F; Aghazadeh R; Zali MR; Hashemi M
    Acta Gastroenterol Belg; 2009; 72(3):301-5. PubMed ID: 19902862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diagnostic accuracy of serologic markers in children with IBD: the West Virginia experience.
    Elitsur Y; Lawrence Z; Tolaymat N
    J Clin Gastroenterol; 2005 Sep; 39(8):670-3. PubMed ID: 16082274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical value of the detection of antibodies in the serum for diagnosis and treatment of inflammatory bowel disease.
    Rutgeerts P; Vermeire S
    Gastroenterology; 1998 Oct; 115(4):1006-9. PubMed ID: 9786723
    [No Abstract]   [Full Text] [Related]  

  • 25. [Relevance of serologic studies in inflammatory bowel diseases].
    Papp M; Altorjay I; Lakatos PL
    Orv Hetil; 2007 May; 148(19):887-96. PubMed ID: 17478404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive and negative predictive values: use of inflammatory bowel disease serologic markers.
    Austin GL; Shaheen NJ; Sandler RS
    Am J Gastroenterol; 2006 Mar; 101(3):413-6. PubMed ID: 16542272
    [No Abstract]   [Full Text] [Related]  

  • 27. Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies: serologic markers in inflammatory bowel disease.
    Hartman C; Eliakim R; Shamir R
    Isr Med Assoc J; 2004 Apr; 6(4):221-6. PubMed ID: 15115261
    [No Abstract]   [Full Text] [Related]  

  • 28. [Diagnostic role of anti-saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease].
    Gao X; Hu PJ; He Y; Liao SY; Peng S; Chen MH
    Zhonghua Nei Ke Za Zhi; 2005 Jun; 44(6):428-30. PubMed ID: 16008854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of serologic markers in indeterminate colitis: a prospective follow-up study.
    Castillo S; Ramaiah B; Blum S; Remy P
    Gastroenterology; 2003 Sep; 125(3):999; author reply 999-1000. PubMed ID: 12974272
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum antibodies for the diagnosis of inflammatory bowel disease: ANCA for ulcerative colitis and ASCA for Crohn's disease.
    Tecnologica MAP Suppl; 1999 Jun; ():18-20. PubMed ID: 10848041
    [No Abstract]   [Full Text] [Related]  

  • 31. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Reese GE; Constantinides VA; Simillis C; Darzi AW; Orchard TR; Fazio VW; Tekkis PP
    Am J Gastroenterol; 2006 Oct; 101(10):2410-22. PubMed ID: 16952282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serological markers (anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic antibodies) in inflammatory bowel disease: diagnostic utility and phenotypic correlation.
    Buckland MS; Mylonaki M; Rampton D; Longhurst HJ
    Clin Diagn Lab Immunol; 2005 Nov; 12(11):1328-30. PubMed ID: 16275949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
    Mokrowiecka A; Gasiorowska A; Małecka-Panas E
    Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet.
    Granito A; Zauli D; Muratori P; Muratori L; Grassi A; Bortolotti R; Petrolini N; Veronesi L; Gionchetti P; Bianchi FB; Volta U
    Aliment Pharmacol Ther; 2005 Apr; 21(7):881-7. PubMed ID: 15801923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
    Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
    Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease.
    Israeli E; Grotto I; Gilburd B; Balicer RD; Goldin E; Wiik A; Shoenfeld Y
    Gut; 2005 Sep; 54(9):1232-6. PubMed ID: 16099791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of pANCA (antineutrophil cytoplasmic antibodies) and ASCA (anti-saccharomyces cerevisiae) in screening for IBD in young children.
    Kugathasan S; Werlin SL
    Inflamm Bowel Dis; 1999 Nov; 5(4):283-4. PubMed ID: 10579122
    [No Abstract]   [Full Text] [Related]  

  • 38. [Possible pathogenic role of vascular, immunologic and genetic factors in certain gastroenterologic disorders].
    Papp M
    Orv Hetil; 2008 Nov; 149(48):2269-76. PubMed ID: 19028649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
    Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
    J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ASCA: genetic marker, predictor of disease, or marker of a response to an environmental antigen?
    Seibold F
    Gut; 2005 Sep; 54(9):1212-3. PubMed ID: 16099786
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.